20.04.2020
- The Paul Ehrlich Institute is the German federal institute for vaccines and biomedicines. Klaus Cichutek has been president of the research institution and medical regulatory body...
20.04.2020
- The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...
08.09.2017
- Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal...
13.07.2017
- French drugmaker Sanofi is gaining access to a new type of flu vaccine after agreeing to buy Protein Sciences, a privately held vaccines biotechnology company based in Meriden...
05.04.2013
- After a lengthy fight, Swiss drugmaker Roche said it had agreed to hand over data from all clinical trials of its best-selling flu drug Tamiflu to a group of outside researchers...
19.01.2013
- Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...
18.01.2013
- Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...
